Register now to ask questions of researchers during the webinar
CAPE CANAVERAL, Fla., Oct. 18, 2024 /PRNewswire/ — The International Space Station (ISS) National Laboratory and NASA will host a webinar to discuss upcoming research and technology development projects launching on SpaceX’s 31st Commercial Resupply Services (CRS) mission for NASA to the orbiting outpost. This webinar will showcase how research on the space station is enabling innovation, benefiting humanity, and driving a sustainable market economy in low Earth orbit. The webinar is scheduled to take place Wednesday, October 23 at 1 p.m. EDT.
Investigations on this mission are slated to launch to the space station onboard a SpaceX Dragon spacecraft in the coming weeks from Launch Complex 39A at NASA’s Kennedy Space Center in Florida.
During the webinar, Kristin Kopperud, ISS National Lab science program director, and Meghan Everett, NASA’s deputy chief scientist for the International Space Station Program, will provide programmatic insights. They will then be joined by the following expected speakers to highlight specific research investigations on the mission:
The webinar will be available on Zoom for media. Members of the media who would like to participate must register for Zoom access no later than one hour in advance.
The public can participate by submitting questions before the webinar using #ISSNationalLab on social media. Following the webinar, a recording will be available on the ISS National Lab YouTube channel. Additional information about ISS National Lab-sponsored projects on this mission will be made available to the media and public in the coming days.
Join us to learn more about the exciting investigations heading to the space station to advance science and benefit humanity.
To download a high-resolution image for this release, click here.
About the International Space Station (ISS) National Laboratory:
The International Space Station (ISS) is a one-of-a-kind laboratory that enables research and technology development not possible on Earth. As a public service enterprise, the ISS National Laboratory® allows researchers to leverage this multiuser facility to improve quality of life on Earth, mature space-based business models, advance science literacy in the future workforce, and expand a sustainable and scalable market in low Earth orbit. Through this orbiting national laboratory, research resources on the ISS are available to support non-NASA science, technology, and education initiatives from U.S. government agencies, academic institutions, and the private sector. The Center for the Advancement of Science in Space™ (CASIS™) manages the ISS National Lab, under Cooperative Agreement with NASA, facilitating access to its permanent microgravity research environment, a powerful vantage point in low Earth orbit, and the extreme and varied conditions of space. To learn more about the ISS National Lab, visit our website.
As a 501(c)(3) nonprofit organization, CASIS accepts corporate and individual donations to help advance science in space for the benefit of humanity. For more information, visit our donations page.
Media Contact: |
Patrick O’Neill |
904-806-0035 |
|
International Space Station (ISS) National Laboratory |
Managed by the Center for the Advancement of Science in Space, Inc. (CASIS) |
6905 N. Wickham Rd., Suite 500, Melbourne, FL 32940 • 321.253.5101 • www.ISSNationalLab.org |
SOURCE International Space Station National Lab
Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…